Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Association between NT-proBNP levels and future cardiovascular events in systemic lupus erythematosus: a multicenter longitudinal cohort study.

Created on 16 Nov 2026

Authors

Arthur Mageau, Drifa Belhadi, Anne Boutten, Kenza Ouacel, Cedric Laouenan, Evelyne Vinet, Veronique Le Guern, Julie Chezel, Nathalie Morel, Pascale Ghillani-Dalbin, Alexis Mathian, Zahir Amoura, Thomas Papo, Sasha Bernatsky, Nathalie Costedoat-Chalumeau, Karim Sacré

Published in

The Journal of rheumatology. Nov 15, 2026. Epub Nov 15, 2026.

Abstract

Current strategies for identifying individuals at high risk of cardiovascular events (CVE) in systemic lupus erythematosus (SLE) are lacking. A previous cross-sectional study in SLE showed that NT-proBNP > 133 pg/mL was associated with cardiovascular damage. Our objective was to assess the association between NT-proBNP at a threshold of 133 and incident CVE in SLE.
All SLE patients who were included in the randomised controlled trial PLUS between 2007 and 2010 in France were screened. Patients with a history of CVE, an unavailable serum sample at PLUS inclusion, or incomplete follow-up were excluded from the primary analysis. The primary endpoint was the occurrence of CVE during follow-up.
A total of 351 patients (out of 573 included in PLUS) were analyzed. Of these patients, 316 (90.0%) were women with a median age of 38 [30-48] years. Among them, 24 (6.8%) patients experienced at least one CVE that occurred a median of 5 [3-7] years after baseline. Five patients had more than one CVE. In the multivariable analysis, age, dyslipidemia and NT-proBNP were significantly associated with the occurrence of CVE. NT-proBNP was >133pg/mL in 22 (6.3%) patients at baseline. The 133 pg/ml threshold was significantly associated with the occurrence of CVE during follow-up (adjusted hazard ratio [CI 95]: 2.94; 95% CI: 1.12-7.71).
A NT-proBNP threshold of 133 pg/ml is associated with future CVE in SLE. SLE care guidelines could consider including NT-proBNP measurement in order to better stratify the cardiovascular prevention strategies in this high-risk population.

PMID:
43035238
Bibliographic data and abstract were imported from PubMed on 16 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement